Skip to main content
SpringerLink
Log in

Diabetes-Related Neuropathies

  • Chapter
  • First Online:
Small Fiber Neuropathy and Related Syndromes: Pain and Neurodegeneration

Abstract

With an estimate of 350 million people in the world having diabetes by the year 2030, diabetes will be an enormous cause of neuropathy. Approximately 50% of those people developing diabetes will develop a clinically significant neuropathy. In addition, the increase in prediabetes prevalence, and the associated increase in neuropathy risk in that cohort, suggests an epidemic of neuropathy that is going to be a challenge for the healthcare system to handle. The majority of individuals with diabetic neuropathy have type 2 diabetes (~95%), although large numbers of individuals with prediabetes are at risk for any associated distal neuropathy as well. Typically individuals with type 1 diabetes do not develop neuropathy until at least 5 years after diagnosis, while those individuals with type 2 diabetes may have neuropathy at the time of diagnosis. Neuropathies can vary in clinical presentation from a distal symmetric neuropathy, mononeuropathy, cranial neuropathy, plexus neuropathy, or even autonomic neuropathy. In this chapter, the clinical presentation, diagnosis, and management of the various diabetes-related neuropathies are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Callaghan BC, Cheng H, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11:521–34.

    Article  PubMed  PubMed Central  Google Scholar 

  2. CDC, National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011, CDC, Editor. 2011, Department of Health and Human Services, Centers for Disease Control and Prevention.

    Google Scholar 

  3. DCCT Research Group. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes. 1988;37:476–81.

    Article  Google Scholar 

  4. Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

    Article  Google Scholar 

  5. Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA, et al. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep. 2010;10:276–82.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419–30.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Callaghan B, Feldman E. The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol. 2013;74:397–403.

    Article  CAS  PubMed  Google Scholar 

  8. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8–14.

    Article  PubMed  Google Scholar 

  9. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the american diabetes association. Diabetes Care. 2017;40:136–54.

    Article  CAS  PubMed  Google Scholar 

  10. Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;6:CD007543.

    Google Scholar 

  11. Callaghan BC, Gao L, Li Y, Zhou X, Reynolds E, Banerjee M, et al. Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. Ann Clin Transl Neurol. 2018;5:397–405.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology. 2003;60:108–11.

    Article  CAS  PubMed  Google Scholar 

  13. Cortez M, Singleton JR, Smith AG. Glucose intolerance, metabolic syndrome, and neuropathy. Handb Clin Neurol. 2014;126:109–22.

    Article  PubMed  Google Scholar 

  14. Peltier A, Goutman SA, Callaghan BC. Painful diabetic neuropathy. BMJ. 2014;348:g1799.

    Article  PubMed  Google Scholar 

  15. Said G. Diabetic neuropathy – a review. Nat Clin Pract Neurol. 2007;3:331–40.

    Article  PubMed  Google Scholar 

  16. Clements RS Jr, Bell DS. Complications of diabetes. Prevalence, detection, current treatment, and prognosis. Am J Med. 1985;79:2–7.

    Article  PubMed  Google Scholar 

  17. Zochodne DW. Diabetic polyneuropathy: an update. Curr Opin Neurol. 2008;21:527–33.

    Article  CAS  PubMed  Google Scholar 

  18. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956–62.

    Article  PubMed  Google Scholar 

  19. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care. 2008;31(Suppl 2):S255–61.

    CAS  PubMed  Google Scholar 

  20. Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011;27:629–38.

    Article  CAS  PubMed  Google Scholar 

  21. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract. 1991;13:63–7.

    Article  CAS  PubMed  Google Scholar 

  22. Callaghan B, McCammon R, Kerber K, Xu X, Langa KM, Feldman E. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med. 2012;172:127–32.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Callaghan BC, Burke JF, Rodgers A, McCammon R, Langa KM, Feldman EL, et al. Expenditures in the elderly with peripheral neuropathy: where should we focus cost-control efforts? Neurol Clin Pract. 2013;3:421–30.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Dworkin RH, O’Connor AB, Audette J, Baron R, Gourlay GK, Haanpää ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85:S3–S14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bohlega S, Alsaadi T, Amir A, Hosny H, Karawagh AM, Moulin D, et al. Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region. J Int Med Res. 2010;38:295–317.

    Article  CAS  PubMed  Google Scholar 

  26. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113–e88.

    Article  CAS  PubMed  Google Scholar 

  27. Hovaguimian A, Gibbons CH. Clinical approach to the treatment of painful diabetic neuropathy. Ther Adv Endocrinol Metab. 2011;2:27–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gibbons CH. Small fiber neuropathies. Continuum (Minneap Minn). 2014;20(5 Peripheral Nervous System Disorders):1398–412.

    Google Scholar 

  29. Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care. 2007;30:2619–25.

    Article  PubMed  Google Scholar 

  30. Sommer C. Painful neuropathies. Curr Opin Neurol. 2003;16:623–8.

    Article  PubMed  Google Scholar 

  31. Zilliox LA, Ruby SK, Singh S, Zhan M, Russell JW. Clinical neuropathy scales in neuropathy associated with impaired glucose tolerance. J Diabetes Complicat. 2015;29:372–7.

    Article  Google Scholar 

  32. Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve. 2006;34:57–61.

    Article  PubMed  Google Scholar 

  33. Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc. 1989;64:617–28.

    Article  CAS  PubMed  Google Scholar 

  34. Stewart JD. Sweating abnormalities and other autonomic disorders in diabetes mellitus. Mayo Clin Proc. 1989;64:712–5.

    Article  CAS  PubMed  Google Scholar 

  35. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2010;17:903–12, e44–9.

    Article  CAS  PubMed  Google Scholar 

  36. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst. 2010;15:202–7.

    Article  PubMed  Google Scholar 

  37. Boruchow SA, Gibbons CH. Utility of skin biopsy in management of small fiber neuropathy. Muscle Nerve. 2013;48:877–82.

    Article  PubMed  Google Scholar 

  38. Illigens BM, Gibbons CH. Sweat testing to evaluate autonomic function. Clin Auton Res. 2009;19(2):79–87.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Freeman R, Chase KP, Risk MR. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology. 2003;60:465–70.

    Article  PubMed  Google Scholar 

  40. Gruener G, Dyck PJ. Quantitative sensory testing: methodology, applications, and future directions. [Review] [45 refs]. J Clin Neurophysiol. 1994;11:568–83.

    Article  CAS  PubMed  Google Scholar 

  41. Dyck PJ, Zimmerman IR, Johnson DM, Gillen D, Hokanson JL, Karnes JL, et al. A standard test of heat-pain responses using CASE IV. J Neurol Sci. 1996;136:54–63.

    Article  CAS  PubMed  Google Scholar 

  42. Dyck PJ, Larson TS, O’Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care. 2000;23:510–7.

    Article  CAS  PubMed  Google Scholar 

  43. Brown MJ, Bird SJ, Watling S, Kaleta H, Hayes L, Eckert S, et al. Natural progression of diabetic peripheral neuropathy in the zenarestat study population. Diabetes Care. 2004;27:1153–9.

    Article  PubMed  Google Scholar 

  44. Bril V, Hirose T, Tomioka S, Buchanan R, Ranirestat Study Group. Ranirestat for the management of diabetic sensorimotor polyneuropathy. Diabetes Care. 2009;32:1256–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Low PA, Benrud-Larson LM, Sletten DM, Opfer-Gehrking TL, Weigand SD, O’Brien PC, et al. Autonomic Symptoms and Diabetic Neuropathy: a population-based study. Diabetes Care. 2004;27:2942–7.

    Article  PubMed  Google Scholar 

  46. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm. 2004;61:160–73.

    Article  CAS  PubMed  Google Scholar 

  47. Maser RE, Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab. 2005;90:5896–903.

    Article  CAS  PubMed  Google Scholar 

  48. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2006;29:334–9.

    Article  PubMed  Google Scholar 

  49. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27:639–53.

    Article  PubMed  Google Scholar 

  50. Chandrasekharan B, Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol Motil. 2007;19:951–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Enck P, Frieling T. Pathophysiology of diabetic gastroparesis. Diabetes. 1997;46(Suppl 2):S77–81.

    Article  CAS  PubMed  Google Scholar 

  52. Kong MF, Horowitz M, Jones KL, Wishart JM, Harding PE. Natural history of diabetic gastroparesis. Diabetes Care. 1999;22:503–7.

    Article  CAS  PubMed  Google Scholar 

  53. Horvath VJ, Izbéki F, Lengyel C, Kempler P, Várkonyi T. Diabetic gastroparesis: functional/morphologic background, diagnosis, and treatment options. Curr Diab Rep. 2014;14:527.

    Article  PubMed  CAS  Google Scholar 

  54. Sellin JH, Chang EB. Therapy Insight: gastrointestinal complications of diabetes – pathophysiology and management. Nat Clin Pract Gastroenterol Hepatol. 2008;5:162–71.

    Article  PubMed  Google Scholar 

  55. Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014;5:17–39.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Nilsson PM. ACCORD and Risk-Factor Control in Type 2 Diabetes. N Engl J Med. 2010;362:1628–30.

    Article  CAS  PubMed  Google Scholar 

  57. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. 2011;161:46–8.

    Article  PubMed  Google Scholar 

  58. Gibbons CH, Freeman R. Clinical implications of delayed orthostatic hypotension: a 10-year follow-up study. Neurology. 2015;85:1362–7.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.

    Article  PubMed  Google Scholar 

  60. Fedele D. Therapy Insight: sexual and bladder dysfunction associated with diabetes mellitus. Nat Clin Pract Urol. 2005;2:282–90.

    Article  PubMed  Google Scholar 

  61. Van Den Eeden SK, Sarma AV, Rutledge BN, Cleary PA, Kusek JW, Nyberg LM, et al. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care. 2009;32:664–70.

    Article  Google Scholar 

  62. Luo KR, Chao CC, Hsieh PC, Lue JH, Hsieh ST. Effect of glycemic control on sudomotor denervation in type 2 diabetes. Diabetes Care. 2012;35:612–6.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Low PA. Autonomic neuropathies. Curr Opin Neurol. 2002;15:605–9.

    Article  PubMed  Google Scholar 

  64. Cheshire WP, Freeman R. Disorders of sweating. Semin Neurol. 2003;23:399–406.

    Article  PubMed  Google Scholar 

  65. Lanting P, Bos JE, Aartsen J, Schuman L, Reichert-Thoen J, Heimans JJ. Assessment of pupillary light reflex latency and darkness adapted pupil size in control subjects and in diabetic patients with and without cardiovascular autonomic neuropathy. J Neurol Neurosurg Psychiatry. 1990;53:912–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2013;369:362–72.

    Article  CAS  PubMed  Google Scholar 

  67. Cryer PE. Hypoglycemia-associated autonomic failure in diabetes. Handb Clin Neurol. 2013;117:295–307.

    Article  PubMed  Google Scholar 

  68. Gibbons CH, Freeman R, Veves A. Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology. Diabetes Care. 2010;33:2629–34.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Buijs RM, Swaab DF. Autonomic nervous system. In Handbook of clinical neurology, volume 117, 3rd series. Edinburgh: Elsevier; 2013.

    Google Scholar 

  70. Illigens BM, Gibbons CH. Sweat testing to evaluate autonomic function. Clin Auton Res. 2009;19:79–87.

    Article  PubMed  Google Scholar 

  71. Freeman R. Assessment of cardiovascular autonomic function. Clin Neurophysiol. 2006;117:716–30.

    Article  PubMed  Google Scholar 

  72. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Low PA, Benarroch EE. Clinical autonomic disorders. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. xii, 780 p., 16 p. of plates.

    Google Scholar 

  74. Freeman R. Autonomic peripheral neuropathy. Lancet. 2005;365:1259–70.

    Article  CAS  PubMed  Google Scholar 

  75. Freeman R. Autonomic peripheral neuropathy. Neurol Clin. 2007;25:277–301.

    Article  PubMed  Google Scholar 

  76. Basu A, Ryder RE. New treatment options for erectile dysfunction in patients with diabetes mellitus. Drugs. 2004;64:2667–88.

    Article  CAS  PubMed  Google Scholar 

  77. Caravati CM. Insulin neuritis: a case report. Va Med Monthly. 1933;59:745–6.

    Google Scholar 

  78. Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67:534–41.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015;138:43–52.

    Article  PubMed  Google Scholar 

  80. Gibbons CH. Treatment induced neuropathy of diabetes: an autonomic dysrecognition syndrome. Clin Auton Res. 2016;26:1.

    Article  Google Scholar 

  81. Group DR. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998;116:874–86.

    Article  Google Scholar 

  82. Gibbons CH. Treatment induced neuropathy of diabetes-long term implications in type 1 diabetes. J Diabetes Complicat. 2017;31:715–20.

    Article  Google Scholar 

  83. Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996;39:329–35.

    Article  CAS  PubMed  Google Scholar 

  84. Sander HW, Chokroverty S. Diabetic amyotrophy: current concepts. [Review] [55 refs]. Semin Neurol. 1996;16:173–8.

    Article  CAS  PubMed  Google Scholar 

  85. Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve. 2002;25:477–91.

    Article  PubMed  Google Scholar 

  86. Callaghan BC, Price RS, Chen KS, Feldman EL. The importance of rare subtypes in diagnosis and treatment of peripheral neuropathy: a review. JAMA Neurol. 2015;72:1510–8.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Younger DS. Diabetic lumbosacral radiculoplexus neuropathy: a postmortem studied patient and review of the literature. J Neurol. 2011;258:1364–7.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Thaisetthawatkul P, Dyck PJ. Treatment of diabetic and nondiabetic lumbosacral radiculoplexus neuropathy. Curr Treat Options Neurol. 2010;12:95–9.

    Article  PubMed  Google Scholar 

  89. Llewelyn JG, Thomas PK, King RH. Epineurial microvasculitis in proximal diabetic neuropathy. J Neurol. 1998;245:159–65.

    Article  CAS  PubMed  Google Scholar 

  90. Tamburin S, Zanette G. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy. Pain Med. 2009;10:1476–80.

    Article  PubMed  Google Scholar 

  91. Tamburin S, Magrinelli F, Favaro F, Briani C, Zanette G. Long-term response of neuropathic pain to intravenous immunoglobulin in relapsing diabetic lumbosacral radiculoplexus neuropathy. A case report. Pain Pract. 2014;14:E85–90.

    Article  PubMed  Google Scholar 

  92. Fraser DM, Campbell IW, Ewing DJ, Clarke BF. Mononeuropathy in diabetes mellitus. Diabetes. 1979;28:96–101.

    Article  CAS  PubMed  Google Scholar 

  93. Albers JW, Brown MB, Sima AA, Greene DA. Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT). Tolrestat Study Group for Edit (Early Diabetes Intervention Trial). Muscle Nerve. 1996;19:140–6.

    Article  CAS  PubMed  Google Scholar 

  94. Hansson S. Segmental median nerve conduction measurements discriminate carpal tunnel syndrome from diabetic polyneuropathy. Muscle Nerve. 1995;18:445–53.

    Article  CAS  PubMed  Google Scholar 

  95. Vinik A, Mehrabyan A, Colen L, Boulton A. Focal entrapment neuropathies in diabetes. Diabetes Care. 2004;27:1783–8.

    Article  PubMed  Google Scholar 

  96. Malkoc M, Korkmaz Ö, Oltulu I, Seker A, Say F, Bulbul AM. Surgical treatment results of carpal tunnel syndrome in patients with and without type 2 diabetes mellitus. Srp Arh Celok Lek. 2014;142:675–9.

    Article  PubMed  Google Scholar 

  97. Gulabi D, Cecen G, Guclu B, Cecen A. Carpal tunnel release in patients with diabetes result in poorer outcome in long-term study. Eur J Orthop Surg Traumatol. 2014;24:1181–4.

    Article  PubMed  Google Scholar 

  98. Thomsen NO, Anderson GS, Björk J, Dahlin LB. Neurophysiological recovery 5 years after carpal tunnel release in patients with diabetes. Muscle Nerve. 2017;56:E59–64.

    Article  PubMed  Google Scholar 

  99. Cornblath DR, Vinik A, Feldman E, Freeman R, Boulton AJ. Surgical decompression for diabetic sensorimotor polyneuropathy. Diabetes Care. 2007;30:421–2.

    Article  PubMed  Google Scholar 

  100. Ross AT. Recurrent cranial nerve palsies in diabetes mellitus. Neurology. 1962;12:180–5.

    Article  CAS  PubMed  Google Scholar 

  101. Pecket P, Schattner A. Concurrent Bell’s palsy and diabetes mellitus: a diabetic mononeuropathy? J Neurol Neurosurg Psychiatry. 1982;45:652–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med. 2016;164:542–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

    Christopher H. Gibbons

Authors
  1. Christopher H. Gibbons
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher H. Gibbons .

Editor information

Editors and Affiliations

  1. Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan

    Sung-Tsang Hsieh

  2. Department of Neurology, Imperial College London, Hammersmith Hospital, London, UK

    Praveen Anand

  3. Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Christopher H. Gibbons

  4. Neurologische Klinik, Universitätsklinikum Würzburg , Würzburg, Germany

    Claudia Sommer

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gibbons, C.H. (2019). Diabetes-Related Neuropathies. In: Hsieh, ST., Anand, P., Gibbons, C., Sommer, C. (eds) Small Fiber Neuropathy and Related Syndromes: Pain and Neurodegeneration. Springer, Singapore. https://doi.org/10.1007/978-981-13-3546-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-3546-4_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-3545-7

  • Online ISBN: 978-981-13-3546-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation